Briana K. Chen et al.; Fluoroethylnormemantine, A novel derivative of memantine, facilitates extinction learning without sensorimotor deficits International Journal of Neuropsychopharmacology (2021)​

Briana K. Chen et al.; Fluoroethylnormemantine, a Novel NMDA Receptor Antagonist, for the Prevention and Treatment of Stress-Induced Maladaptive Behavior. Biological Psychiatry (2021) ​

Langreck, Cory B. et al.; Mu Opioid Receptor Activation is Required for NMDA Receptor Antagonist Effects on Stress-induced Maladaptive Behavior, Biological Psychiatry (2025)​

Simon Couly et al.; Anti-amnesic and neuroprotective effects of Fluoroethylnormemantine in a pharmacological mouse model of Alzheimer’s disease; International Journal of Neuropsychopharmacology (2020)

Allison Carles et al.; Neuroprotective effects of Fluoroethylnormemantine (FENM) in the Aß25-35 mouse model of Alzheimer’s disease: chronic infusion by Alzet pumps and long-term efficacy; Neurosciences (2022)​

Freyssin A, Carles A, Guehairia S, Rubinstenn G, Maurice T. Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer’s disease. Neuropharmacology (2023)​

Freyssin, A., Carles, A., Moha, B., Rubinstenn, G., & Maurice, T. (2024). Long-Term Treatment with Fluoroethylnormemantine(FENM) Alleviated Memory Deficits, Amyloid Pathology, and Microglial Reaction in APP/PS1 Mice. ACS Pharmacology &Translational Science, 7(12) (2024)

Carles, A., Freyssin, A., Guehairia, S., Reguero, T., Vignes, M., Hirbec, H., Rubinstenn, G., & Maurice, T. Neuroprotection byChronic Administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer’s disease. Alzheimer’s Research& Therapy, 17(1) (2025)

Anne-Sophie Salabert et al.; Radiolabeling of [18F]-fluoroethylnormemantine and initial in vivo evaluation of this innovative PET tracer for imaging the PCP sites of NMDA receptors; Nuclear Medicine and Biology (2015)

Anne-Sophie Salabert et al.; Evaluation of [18F]FNM biodistribution and dosimetry based on whole-body PET imaging of rats; Nuclear Medicine and Biology (2018)​

Marie Beaurain et al.; Pharmacological Characterization of [18F]-FNM and Evaluation of NMDA Receptors Activation in a Rat Brain Injury Model; Mol Imaging Biol. (2023)